Differential Characteristics of Ischemic and Hemorrhagic Stroke in Patients with Cerebral Small Vessel Disease

被引:10
|
作者
Bernal, Mireia [1 ]
Escarcena, Paula [1 ]
Arboix, Adria [1 ]
Garcia-Eroles, Lluis [2 ]
Verges, Enric [1 ]
Diez, Laura [1 ]
Massons, Joan [1 ]
机构
[1] Univ Barcelona, Hosp Univ Sagrat Cor, Dept Neurol, Cerebrovasc Div, Barcelona, Catalonia, Spain
[2] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Org & Sistemes Informacio, Barcelona, Catalonia, Spain
基金
中国国家自然科学基金;
关键词
Cerebral small vessel disease; lacunar stroke; subcortical hemorrhage; RISK-FACTOR PROFILES; SYMPTOMATIC LACUNAR STROKE; INTRACEREBRAL HEMORRHAGE; INFARCTION; SUBTYPES; ANTICOAGULATION;
D O I
10.4103/0028-3886.310106
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Small vessel disease (SVD) is the underlying anatomical substrate for both lacunar infarction and subcortical hemorrhage. Aim: To assess predictive factors of ischemic or hemorrhagic stroke in patients with cerebral SVD. Materials and Methods: Prospective hospital-based stroke registry ("The Sagrat Cor Hospital of Barcelona Stroke Registry") in an acute-care teaching hospital in Barcelona, Spain. From 4597 acute stroke patients included in the stroke registry over a 24-year period, 440 cases of lacunar stroke and 210 of subcortical intracerebral hemorrhage were selected. Demographics, clinical characteristics, risk factors, and early outcome were compared. Predictors of lacuna versus subcortical hemorrhage were assessed by multivariate analyses. Results: In a logistic regression model based on demographics, risk factors, clinical features and outcome, dyslipidemia (odds ratio [OR] 2.06 (95% confidence interval (CI) 1.17-3.62) and diabetes (OR 1.97, 95% CI 1.19-3.26) were independent risk factors for lacunar infarction. Anticoagulation therapy (OR 0.05, 95% CI 0.01-0.28), sudden onset (OR 0.51, 95% CI 0.33-0.78), motor symptoms (OR 0.44, 95% CI 0.26-0.76), headache (OR 0.23, 95% CI 0.12-0.41), altered consciousness (OR 0.10, 95% CI 0.05-0.21), respiratory complications (OR 0.19, 95% CI 0.08-0.46), and in-hospital death (OR 0.08, 95% CI 0.02-0.36) were predictors of subcortical hemorrhage. Conclusion: Identification of differential clinical and prognostic profile between ischemic and hemorrhagic consequences of underlying cerebral SVD is useful for risk stratification in the current process pursuing precision medicine.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 50 条
  • [31] Plasma osteoprotegerin levels are associated with the presence and burden of cerebral small vessel disease in patients with acute ischemic stroke
    Park, Moo-Seok
    Chang, Yoonkyung
    Kim, Kwang-Hyun
    Park, Jin Hee
    Song, Tae-Jin
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 210
  • [32] Accelerated development of cerebral small vessel disease in young stroke patients
    Arntz, Renate M.
    van den Broek, Steffen M. A.
    van Uden, Inge W. M.
    Ghafoorian, Mohsen
    Platel, Bram
    Rutten-Jacobs, Loes C. A.
    Maaijwee, Noortje A. M.
    Schaapsmeerders, Pauline
    Schoonderwaldt, Hennie C.
    van Dijk, Ewoud J.
    de Leeuw, Frank-Erik
    NEUROLOGY, 2016, 87 (12) : 1212 - 1219
  • [33] Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?
    Grau-Olivares, Marta
    Arboix, Adria
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1201 - 1217
  • [34] Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients
    Tomohisa Nezu
    Naohisa Hosomi
    Shiro Aoki
    Kazushi Deguchi
    Hisashi Masugata
    Noriko Ichihara
    Hideo Ohyama
    Toshiho Ohtsuki
    Masakazu Kohno
    Masayasu Matsumoto
    Journal of Neurology, 2013, 260 : 2642 - 2649
  • [35] Effect of Cerebral Small Vessel Disease Burden on Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment
    Huang, Hao
    Zong, Weifeng
    Tong, Xu
    Tian, Xue
    Wang, Anxin
    Jia, Baixue
    Zhao, Jing
    Wu, Lingshan
    Zhou, Xirui
    Guo, Yinping
    Zhang, Yi
    Yu, Zhiyuan
    Wang, Yilong
    Wang, Yongjun
    Luo, Xiang
    Miao, Zhongrong
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [36] The Relationship Between Chronic Kidney Diseases and the Presence of Cerebral Small Vessel Disease in Patients With Acute Ischemic Stroke
    Ueki, Kana
    Nakamura, Asako
    Yasaka, Masahiro
    Kuwashiro, Takahiro
    Gotoh, Seiji
    Takaguchi, Go
    Nakanishi, Yasuyuki
    Okada, Yasushi
    STROKE, 2017, 48
  • [37] Alpha2-macroglobulin as a promising biomarker for cerebral small vessel disease in acute ischemic stroke patients
    Nezu, Tomohisa
    Hosomi, Naohisa
    Aoki, Shiro
    Deguchi, Kazushi
    Masugata, Hisashi
    Ichihara, Noriko
    Ohyama, Hideo
    Ohtsuki, Toshiho
    Kohno, Masakazu
    Matsumoto, Masayasu
    JOURNAL OF NEUROLOGY, 2013, 260 (10) : 2642 - 2649
  • [38] Cerebral Small Vessel Disease Burden and Futile Reperfusion after Endovascular Treatment for Patients with Acute Ischemic Stroke
    Lee, Minwoo
    Kim, Yerim
    Oh, Mi Sun
    Yu, Kyung-Ho
    Lee, Byung-Chul
    Kim, Chul-Ho
    Mo, Hee Jung
    Lee, Sang-Hwa
    CEREBROVASCULAR DISEASES, 2023, 52 (04) : 427 - 434
  • [39] Dolichoectasia of the Basilar Artery is Associated With Cerebral Small Vessel Disease and Microbleeds in Young TIA and Ischemic Stroke Patients
    Thijs, Vincent
    Grittner, Ulrike
    Fazekas, Franz
    McCabe, Dominick
    Giese, Anne-Katrin
    Kessler, Christoph
    Martus, Peter
    Norrving, Bo
    Tanislav, Christian
    Ringelstein, Bernd
    Tatlisumak, Turgut
    Rolfs, Arndt
    Enzinger, Christian
    STROKE, 2016, 47
  • [40] Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemic Stroke: A Pilot Study
    Xia, Min
    Wu, Daizong
    Yu, Nengwei
    Huang, Guoxiang
    MEDICAL SCIENCE MONITOR, 2025, 31